Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

View source ↗

Summary

A clinical trial update noting ongoing recruitment for a study evaluating the nutritional impacts of Palynziq (pegvaliase) in people with phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Sponsor: Emory University | Conditions: Phenylketonurias | Status: RECRUITING